Tag | Content |
---|
EnhancerAtlas ID | HS012-06983 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr11:128452410-128454440 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
TEAD1 | MA0090.2 | chr11:128454270-128454280 | CACATTCCAT | + | 6.02 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_00763 | chr11:128442551-128457994 | Adipose_Nuclei | SE_40667 | chr11:128452787-128453368 | Left_Ventricle | SE_54090 | chr11:128452685-128453411 | Spleen |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH11I128582 | chr11 | 128452381 | 128453495 | GH11I128584 | chr11 | 128454201 | 128454310 |
|
Enhancer Sequence | CTTTTTTCTA CTGCCCAACA TGGCAGAGGT TATTTAAGTG TTAGAGCTAG AACATGGATA 60 GCTAAATCTC TCATCTCTTT TTCTAAAGAC TTGTATTCAA GTCATGAAAA CAGGATTCCC 120 TTTCATAATC ATAGGTTGAG TAGCATTAGT CAAGAATTTT GCAGGAGAAA AGAGCCACAA 180 TTTCTGTTTA ATGGTAGTCT GTTTGTACCA TTGTTATGCA TAAAACCAAG AAGTAAGCAT 240 TTTTCTTACA GTGGAGAACT AACTCATTGA AAGATTGCAT AGCACAAATG GTGAAATATT 300 GCAGCTTCCT GAGTTAAACC AACATCTTTT TGATATAATG TCGATCTTTT GTGGACTTAC 360 GCTTTAGCAA CTAGATACAA ATATAAGGAA GTAGTAAAGC ACTGCGGAAA ATAGTGCAAG 420 ATTTCTTGTT TGTTCATTTT TTTCATTTTT GCTTTTTCAT TTGTTTTTGC TTTTTCTTTA 480 GAGCAGTGCC TCCCAAACTG TAATGTGCAT ATGAATCACC CGGGGATCCT GTTACAATGC 540 AGTCTGCTGC AGTAGGTCTG AGGTCTGGCC AGACATTCCA CATTTCTAAC AAGCTCCCAC 600 GTGGTGCTGA TGCCGCAGGT CAGAGGACTT CACTGTGAGT AGCAAGGCAG CGCTGGACTA 660 ACTTGGTTGA ACTCATGAGT GATTATAACA AGGTAGGTGT TTAGGAGGCA GAGCCCAAGG 720 AGGAACAGGC AAGACTTCTG TGCCAAGGCT GAGCAGATGC TGGTAACCTC AGGTGCAATA 780 CAAACCCGGC TGGGGAGAAT TGAGTAGCTC AGGACCTGTC AGTGTCTCAG GAGCCATATG 840 CCAGATGCAC ATCTGCCAAG ACTTCTTGCT TTTCCTAAGA AGACATGGTT CTAGTTATTT 900 GGTCCCTTTT ATCAAGAAAC TGGCAATGGT GCTTTCTCCC ATCAACAGAA GTCATTTGGA 960 TTAAGGATTA CAAGAGGTGC CAAGAGATAA TTTAAAAGAG TTATTTGCAT TATATGTTTT 1020 TTTTTACAAT TGTAAAAGAC TCACATGTTT TGGAAACTTT TTGTACATTG TTTTGCAAAC 1080 TTTTATGCAT CTGGAATTAT TTCAAAGTGA AAAGTTTTTT TTAAGTCTCT AAAAAGACTA 1140 AATCTCTTTT AAATCTCTAA AAAGACCAAA ATTCTGGAGT TTTCTACCTT TCCACATCTC 1200 TTGAAAATTT ATATATTTTT TCCTCCCCAT TGAGAATATT TTCCTGACAT TTGCACTAAA 1260 TGTTTGTTGC TTACTCTCAT GCTAGTAAGT ACTACCCAGC CTGTTCCCTC TAAGTTCTGA 1320 AGGCAGCTCC AACACTTGAT TACTGGAATA TGAAATCTAT CCTCTTTTGA AAAAAAGGCA 1380 GATCAGAAAC ATCCTTCCCT CACTGCTCTA GATACCATTT TTTTCTACCT GAACTCCCAA 1440 AGCATGTATA GGTTATACTA CACTACTTAA TAATTATATT GTCTTTCATT TTTATCCTCT 1500 TTTCTAGTAA AGATTATTGT GTTAATTTTA AAAATGGAGT TTACATATTG TTTCTTCTGT 1560 GTTTGGTATG GTCTCCAGCA CAAGGCTGGG CATGGAGTAG AAATAAAACT GATATTTGTC 1620 AGGGAAGGGA CTGACTTACT TACCCAGGAA ACTAGGCCTG GGTAGTCTTT CTTCAAAGTC 1680 AGTATCTTCA TAACAATGAA TAAGTAATCC ACAGATACCA CTTCAGAAAA CAGGCTTAAT 1740 CCAGTGTTCT CCTAGATAAG CAAATCAGTC TAAGCAGAAA AATCTATCCT AAATTTGTGT 1800 AAATGTCTTA GAGTTACTTA GATTCCTATG ACATGCAGTT CCAATCACAA GCTCTGGGTT 1860 CACATTCCAT TGGCTCTAAT CAGGGTCCAC CATGAGTTAA CACGGTCATA TGACTGAGCC 1920 TCAGAGTCCC CACCTGGTAA ATGGGGATGA CGAGAGTGGA GTGCCCACCT CAAAACTTCA 1980 TTGTAGATTA AATGAAGCAG TCCCTGCAAA GCACCTAGCA AGGATGTTGG 2030
|